- Home
- ARE vs ICLR Comparison
ARE vs ICLR Comparison
Compare ARE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARE | ICLR |
|---|---|---|
| Founded | 1994 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 14.3B |
| IPO Year | 1997 | 1998 |
Fundamental Metrics
Financial Performance| Metric | ARE | ICLR |
|---|---|---|
| Price | $45.76 | $185.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $69.38 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 2.9M | 1.0M |
| Earning Date | 10-27-2025 | 10-22-2025 |
| Dividend Yield | ★ 10.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.47 |
| Revenue | $3,058,395,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $0.76 |
| P/E Ratio | ★ N/A | $24.87 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $45.47 | $125.10 |
| 52 Week High | $107.19 | $228.29 |
Technical Indicators
Market Signals| Indicator | ARE | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 25.29 | 62.18 |
| Support Level | $52.39 | $174.13 |
| Resistance Level | $54.17 | $191.15 |
| Average True Range (ATR) | 1.84 | 8.46 |
| MACD | 0.30 | 2.87 |
| Stochastic Oscillator | 0.06 | 85.77 |
Price Performance
Historical ComparisonAbout ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.